These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 37891003)
1. Exploring the basis of heterogeneity of cancer aggressiveness among the mutated POLE variants. Selves J; de Castro E Gloria H; Brunac AC; Saffi J; Guimbaud R; Brousset P; Hoffmann JS Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37891003 [TBL] [Abstract][Full Text] [Related]
2. POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East. Siraj AK; Bu R; Iqbal K; Parvathareddy SK; Masoodi T; Siraj N; Al-Rasheed M; Kong Y; Ahmed SO; Al-Obaisi KAS; Victoria IG; Arshad M; Al-Dayel F; Abduljabbar A; Ashari LH; Al-Kuraya KS Mol Genet Genomic Med; 2020 Aug; 8(8):e1368. PubMed ID: 32567205 [TBL] [Abstract][Full Text] [Related]
3. Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response. Temko D; Van Gool IC; Rayner E; Glaire M; Makino S; Brown M; Chegwidden L; Palles C; Depreeuw J; Beggs A; Stathopoulou C; Mason J; Baker AM; Williams M; Cerundolo V; Rei M; Taylor JC; Schuh A; Ahmed A; Amant F; Lambrechts D; Smit VT; Bosse T; Graham TA; Church DN; Tomlinson I J Pathol; 2018 Jul; 245(3):283-296. PubMed ID: 29604063 [TBL] [Abstract][Full Text] [Related]
4. DNA Polymerase ɛ Deficiency Leading to an Ultramutator Phenotype: A Novel Clinically Relevant Entity. Castellucci E; He T; Goldstein DY; Halmos B; Chuy J Oncologist; 2017 May; 22(5):497-502. PubMed ID: 28465371 [TBL] [Abstract][Full Text] [Related]
5. Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity. Shah SM; Demidova EV; Ringenbach S; Faezov B; Andrake M; Gandhi A; Mur P; Viana-Errasti J; Xiu J; Swensen J; Valle L; Dunbrack RL; Hall MJ; Arora S Cancer Res Commun; 2024 Jan; 4(1):213-225. PubMed ID: 38282550 [TBL] [Abstract][Full Text] [Related]
6. POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction. Li Y; Bian Y; Wang K; Wan XP BMC Med Genet; 2019 Dec; 20(1):202. PubMed ID: 31864301 [TBL] [Abstract][Full Text] [Related]
7. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer. Church DN; Briggs SE; Palles C; Domingo E; Kearsey SJ; Grimes JM; Gorman M; Martin L; Howarth KM; Hodgson SV; ; Kaur K; Taylor J; Tomlinson IP Hum Mol Genet; 2013 Jul; 22(14):2820-8. PubMed ID: 23528559 [TBL] [Abstract][Full Text] [Related]
9. The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management. Palles C; Martin L; Domingo E; Chegwidden L; McGuire J; Cuthill V; Heitzer E; ; Kerr R; Kerr D; Kearsey S; Clark SK; Tomlinson I; Latchford A Fam Cancer; 2022 Apr; 21(2):197-209. PubMed ID: 33948826 [TBL] [Abstract][Full Text] [Related]
10. DNA polymerase ε and δ variants drive mutagenesis in polypurine tracts in human tumors. Ostroverkhova D; Tyryshkin K; Beach AK; Moore EA; Masoudi-Sobhanzadeh Y; Barbari SR; Rogozin IB; Shaitan KV; Panchenko AR; Shcherbakova PV Cell Rep; 2024 Jan; 43(1):113655. PubMed ID: 38219146 [TBL] [Abstract][Full Text] [Related]
11. Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps. Elsayed FA; Tops CMJ; Nielsen M; Ruano D; Vasen HFA; Morreau H; J Hes F; van Wezel T Mol Genet Genomic Med; 2019 Apr; 7(4):e00603. PubMed ID: 30827058 [TBL] [Abstract][Full Text] [Related]
12. Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer. Fang H; Barbour JA; Poulos RC; Katainen R; Aaltonen LA; Wong JWH PLoS Genet; 2020 Feb; 16(2):e1008572. PubMed ID: 32012149 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer. Stasenko M; Tunnage I; Ashley CW; Rubinstein MM; Latham AJ; Da Cruz Paula A; Mueller JJ; Leitao MM; Friedman CF; Makker V; Soslow RA; DeLair DF; Hyman DM; Zamarin D; Alektiar KM; Aghajanian CA; Abu-Rustum NR; Weigelt B; Cadoo KA Gynecol Oncol; 2020 Jan; 156(1):194-202. PubMed ID: 31757464 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer. Veneris JT; Lee EK; Goebel EA; Nucci MR; Lindeman N; Horowitz NS; Lee L; Raut CP; Crotzer D; Matulonis U; Konstantinopoulos PA; Campos S Gynecol Oncol; 2019 Jun; 153(3):471-478. PubMed ID: 30935717 [TBL] [Abstract][Full Text] [Related]
15. Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma. Hoang LN; McConechy MK; Köbel M; Anglesio M; Senz J; Maassen M; Kommoss S; Meng B; Postovit L; Kelemen LE; Staebler A; Brucker S; Krämer B; McAlpine JN; Gilks CB; Huntsman DG; Lee CH Int J Gynecol Cancer; 2015 Sep; 25(7):1187-93. PubMed ID: 26166557 [TBL] [Abstract][Full Text] [Related]
16. Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors. Lee M; Eng G; Barbari SR; Deshpande V; Shcherbakova PV; Gala MK Clin Transl Gastroenterol; 2020 Mar; 11(3):e00149. PubMed ID: 32352724 [TBL] [Abstract][Full Text] [Related]
17. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma. Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219 [TBL] [Abstract][Full Text] [Related]
19. POLE somatic mutations in advanced colorectal cancer. Guerra J; Pinto C; Pinto D; Pinheiro M; Silva R; Peixoto A; Rocha P; Veiga I; Santos C; Santos R; Cabreira V; Lopes P; Henrique R; Teixeira MR Cancer Med; 2017 Dec; 6(12):2966-2971. PubMed ID: 29072370 [TBL] [Abstract][Full Text] [Related]
20. The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis. Jumaah AS; Al-Haddad HS; McAllister KA; Yasseen AA PLoS One; 2022; 17(2):e0263585. PubMed ID: 35139130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]